In 2024, Vanderbilt Health investigators received funding from the National Institute on Aging (NIA) for a phase 3, multicenter, placebo-controlled trial to evaluate the efficacy of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results